dc.contributor.author | Silverstein, Peter S. | |
dc.contributor.author | Audus, Kenneth L. | |
dc.contributor.author | Qureshi, Nilofer | |
dc.contributor.author | Kumar, Anil | |
dc.date.accessioned | 2017-05-24T17:31:21Z | |
dc.date.available | 2017-05-24T17:31:21Z | |
dc.date.issued | 2010-12 | |
dc.identifier.citation | Silverstein, P. S., Audus, K. L., Qureshi, N., & Kumar, A. (2010). Lipopolysaccharide Increases the Expression of Multidrug Resistance-Associated Protein 1 (ABCC1) in Macrophages. Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, 5(4), 516–520. http://doi.org/10.1007/s11481-009-9180-4 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24297 | |
dc.description.abstract | Multidrug resistance-associated protein 1 (MRP-1) is a ubiquitously expressed member of the ATP-binding cassette transporter family. MRP-1 is one of the primary transporters of glutathione and glutathione conjugates. This protein also transports antiretroviral therapeutics, such as HIV-1 protease inhibitors (PI). We hypothesized that inflammatory mediators that activate macrophages would modify the expression and activity of MRP-1 in macrophages. Real time PCR assays western blots and calcein efflux assays were used to show that exposure of macrophage cell line RAW 264.7 to LPS increased expression of MRP-1 at the level of mRNA and protein, as well as at the level of functional activity. Treatment of macrophages with LPS resulted in 2-fold increases of MRP-1 expression or functional activity. LPS-mediated increases in calcein efflux were repressed by the MRP-specific inhibitor MK-571. These results suggest that the effectiveness of HIV-1 PI therapy may be compromised by the presence of opportunistic infections. | en_US |
dc.publisher | Springer Verlag | en_US |
dc.rights | © Springer Science+Business Media, LLC 2009 | en_US |
dc.title | Lipopolysaccharide Increases the Expression of Multidrug Resistance-Associated Protein 1 (ABCC1) in Macrophages | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Audus, Kenneth L. | |
kusw.kudepartment | Pharmaceutical Chemistry | en_US |
dc.identifier.doi | 10.1007/s11481-009-9180-4 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC4051155 | en_US |
dc.rights.accessrights | openAccess | |